The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics.

Abbott, NL.; Chauvie, S.; Marcu, L.; DeJean, C.; Melidis, C.; Wientjes, R.; Gasnier, A.; Lisbona, A.; Luzzara, M.; Mazzoni, LN.; O'Doherty, J.; Koutsouveli, E.; Appelt, A.; Hansen, CR.

The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics.

All Authors

Abbott, NL.

Chauvie, S.

Marcu, L.

DeJean, C.

Melidis, C.

Wientjes, R.

Gasnier, A.

Lisbona, A.

Luzzara, M.

Mazzoni, LN.

Show 4 more

LTHT Author

Appelt, Ane

LTHT Department

Leeds Cancer Centre
Oncology
Medical Physics & Engineering

Non Medic

Physicist

Publication Date

2024

Item Type

Journal Article

Abstract

The EFOMP working group on the Role of Medical Physics Experts (MPEs) in Clinical Trials was established in 2010, with experts from across Europe and different areas of medical physics. Their main aims were: (1) To develop a consensus guidance document for the work MPEs do in clinical trials across Europe. (2) Complement the work by American colleagues in AAPM TG 113 and guidance from National Member Organisations. (3) To cover external beam radiotherapy, brachytherapy, nuclear medicine, molecular radiotherapy, and imaging. This document outlines the main output from this working group. Giving guidance to MPEs, and indeed all Medical Physicists (MP) and MP trainees wishing to work in clinical trials. It also gives guidance to the wider multidisciplinary team, advising where MPEs must legally be involved, as well as highlighting areas where MPEs skills and expertise can really add value to clinical trials.